Eversheds Sutherland (International) LLP | European Union | 28 Feb 2024
The German Medical Technology Association and the EPP Group in the European parliament, among others, are calling for a swift agreement on a catalogue of measures to avert negative consequences for patient care and securement of the supply of medical devices in the European Union and thus to amend the EU Medical Device Regulation.
Eversheds Sutherland (International) LLP | Global | 21 Feb 2024
The Medicines and Healthcare products Regulatory Agency recently published a timeline detailing a roadmap of reforms to the UK medical device regulations in order to offer medical device providers and the health tech industry more clarity and an opportunity to prepare for reforms.
Eversheds Sutherland (International) LLP | Global | 21 Feb 2024
Switzerland is working on the requirements for accepting products with a Food and Drug Administration (FDA) clearance in Switzerland, which is expected to be achieved in 2024.
Eversheds Sutherland (International) LLP | United Kingdom | 15 Feb 2024
This checklist will assist in-house counsel and risk and compliance teams with the steps that their organisation should take when dealing with an unannounced inspection or dawn raid.
Eversheds Sutherland (International) LLP | European Union | 2 Feb 2024
The EU Data Act (Data Act) was recently published and is now officially in force as of 11 January 2024.